Clinical Trials Browser

Phase 1/2 × Immunoglobulin Light-chain Amyloidosis × daratumumab × Clear all

NCT05451771 2025-07-08

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Phase 1/2 Recruiting

Immunoglobulin Light-chain Amyloidosis, Proteostasis Deficiencies

NCT02841033 2021-05-07

Daratumumab for the Treatment of Patients With AL Amyloidosis

Phase 1/2 Completed

22 enrolled 10 charts

Immunoglobulin Light-chain Amyloidosis